CNS Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Houston, TX
SEC filing record 1 source field available
Fiscal year end
31 December
CNS Pharmaceuticals, Inc. has filed 380 SEC EDGAR filings since 13 Mar 2018

SEC filing history

Showing 126-150 of 380 matching filings.

Per page
25
Current page
6
DEF 14A File 001-39126

DEFINITIVE PROXY STATEMENT

Filing date
10 Apr 2024
Reporting date
30 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
01 Apr 2024
Reporting date
01 Apr 2024
Next action
Verify source filing
10-K File 001-39126

FORM 10-K FOR 12-31-23

Filing date
01 Apr 2024
Reporting date
31 Dec 2023
Next action
Verify source filing
PRE 14A File 001-39126

FORM PRE14A

Filing date
28 Mar 2024
Reporting date
30 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-93973

SC 13G/A filing

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Feb 2024
Reporting date
01 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Feb 2024
Reporting date
01 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Feb 2024
Reporting date
01 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Feb 2024
Reporting date
01 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Feb 2024
Reporting date
01 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
06 Feb 2024
Reporting date
01 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-275973

FORM 424B4

Filing date
31 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-275973

EFFECT filing

Filing date
29 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
26 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
26 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
25 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
25 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
24 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
24 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-275973

AMENDMENT NO 2

Filing date
22 Jan 2024
Reporting date
Not listed
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
18 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .